Immuron (IMRN) Short Interest Ratio & Short Volume → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free IMRN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisCompetitorsHeadlinesShort InterestSocial MediaStock AnalysisCompetitorsHeadlinesShort InterestSocial Media Immuron Short Interest DataCurrent Short Interest14,700 sharesPrevious Short Interest24,400 sharesChange Vs. Previous Month-39.75%Dollar Volume Sold Short$32,634.00Short Interest Ratio0.0 Days to CoverLast Record DateApril 30, 2024Outstanding Shares5,700,000 sharesPercentage of Shares Shorted0.26%Today's Trading Volume4,930 sharesAverage Trading Volume6,169 sharesToday's Volume Vs. Average80% Short Selling Immuron ? Sign up to receive the latest short interest report for Immuron and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIMRN Short Interest Over TimeIMRN Days to Cover Over TimeIMRN Percentage of Float Shorted Over Time Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. Immuron Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202414,700 shares $32,634.00 -39.8%N/A0 $2.22 4/15/202424,400 shares $63,196.00 -5.1%N/A0 $2.59 3/31/202425,700 shares $67,591.00 -49.8%N/A0 $2.63 3/15/202451,200 shares $146,944.00 +25,500.0%N/A0.1 $2.87 2/29/2024200 shares $344.00 -83.3%N/A0 $1.72 2/15/20241,200 shares $2,171.76 -83.3%N/A0.3 $1.81 Get the Latest News and Ratings for IMRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immuron and its competitors with MarketBeat's FREE daily newsletter. 1/31/20247,200 shares $13,449.60 -41.5%N/A2.5 $1.87 1/15/202412,300 shares $24,108.00 -7.5%N/A4.6 $1.96 12/31/202313,300 shares $24,937.50 -15.8%N/A4.5 $1.88 12/15/202315,800 shares $31,442.00 -19.8%N/A5.3 $1.99 11/30/202319,700 shares $41,764.00 +18.0%N/A6 $2.12 11/15/202316,700 shares $30,061.67 -7.2%N/A5.2 $1.80 10/31/202318,000 shares $28,620.00 -12.6%N/A5.3 $1.59 10/15/202320,600 shares $38,728.00 +3.0%N/A5.6 $1.88 9/30/202320,000 shares $39,600.00 -26.7%N/A5.3 $1.98 9/15/202327,300 shares $52,689.00 -22.2%N/A5.7 $1.93 8/31/202335,100 shares $65,637.00 -8.4%N/A5.5 $1.87 8/15/202338,300 shares $76,217.00 -13.4%N/A4.5 $1.99 7/31/202344,200 shares $86,190.00 -13.3%N/A0.1 $1.95 7/15/202351,000 shares $104,616.30 -4.5%N/A0.1 $2.05 6/30/202353,400 shares $107,868.00 -5.3%N/A0.2 $2.02 6/15/202356,400 shares $112,800.00 +17.0%N/A0.2 $2.00 5/31/202348,200 shares $98,569.00 -48.6%N/A0.1 $2.05 5/15/202393,800 shares $210,112.00 No ChangeN/A0.3 $2.24 7/31/20222,800 shares $6,580.00 -3.5%N/A0.5 $2.35 7/15/20222,900 shares $7,221.00 -29.3%N/A0.5 $2.49 6/30/20224,100 shares $8,774.00 +115.8%N/A0.6 $2.14 6/15/20221,900 shares $5,130.00 +280.0%N/A0.3 $2.70 5/31/2022500 shares $1,420.00 -77.3%N/A0.1 $2.84 5/15/20222,200 shares $6,050.00 -26.7%N/A0.2 $2.75 4/30/20223,000 shares $9,330.00 -82.5%N/A0.2 $3.11 4/15/202217,100 shares $50,616.00 +216.7%N/A0.3 $2.96 3/31/20225,400 shares $18,144.00 -70.7%N/A0 $3.36 3/15/202218,400 shares $52,992.00 +217.2%N/A0 $2.88 2/28/20225,800 shares $16,820.00 -41.4%N/A0 $2.90 2/15/20229,900 shares $31,284.00 -92.5%N/A0 $3.16 1/31/2022131,400 shares $541,368.00 -88.9%N/A0.1 $4.12 1/15/20221,180,000 shares $4.00 million +1,254.8%N/A0 $3.39 12/31/202187,100 shares $217,750.00 No ChangeN/A2 $2.50 6/15/20215,600 shares $27,160.56 +100.0%N/A0.5 $4.85Obama’s Forever Term [exposed] (Ad)Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America. Start streaming it now at no cost here 5/28/20212,800 shares $13,580.28 -71.7%N/A0.2 $4.85 5/14/20219,900 shares $47,916.00 +1,550.0%N/A0.4 $4.84 4/30/2021600 shares $3,324.00 +100.0%N/A0 $5.54 4/15/2021300 shares $1,659.00 +200.0%N/A0 $5.53 3/31/2021100 shares $583.00 -93.3%N/A0 $5.83 3/15/20211,500 shares $9,720.00 +400.0%N/A0 $6.48 2/26/2021300 shares $2,070.00 -99.0%N/A0 $6.90 2/12/202130,600 shares $248,166.00 +595.5%N/A0.3 $8.11 1/29/20214,400 shares $29,788.00 -27.9%N/A0 $6.77 1/15/20216,100 shares $42,212.00 -75.6%N/A0 $6.92 12/31/202025,000 shares $164,750.00 +53.4%N/A0.2 $6.59 12/15/202016,300 shares $114,100.00 -13.8%N/A0.1 $7.00 11/30/202018,900 shares $139,669.11 -83.7%N/A0.2 $7.39 11/15/2020116,200 shares $851,746.00 +773.7%N/A0.9 $7.33 10/30/202013,300 shares $93,366.00 +56.5%N/A0.1 $7.02 10/15/20208,500 shares $69,275.00 +32.8%N/A0 $8.15 9/30/20206,400 shares $48,000.00 -36.6%N/A0 $7.50 9/15/202010,100 shares $85,850.00 -17.9%N/A0 $8.50 8/31/202012,300 shares $112,545.00 +0.8%N/A0 $9.15 8/14/202012,200 shares $135,176.00 -66.4%N/A0 $11.08 7/31/202036,300 shares $363,363.00 +145.3%N/A0 $10.01 7/15/202014,800 shares $88,948.00 -19.1%N/A0 $6.01 6/30/202018,300 shares $135,786.00 -91.2%N/A0 $7.42 6/15/2020207,300 shares $1.99 million +6,378.1%N/A0.1 $9.60 5/29/20203,200 shares $6,720.00 +3,100.0%N/A0 $2.10 5/15/2020100 shares $193.38 -97.0%N/A0 $1.93 4/30/20203,300 shares $8,316.33 -5.7%N/A0.1 $2.52 4/15/20203,500 shares $7,000.00 +12.9%N/A0.1 $2.00 3/31/20203,100 shares $8,742.00 No ChangeN/A0.3 $2.82 3/13/20203,100 shares $6,696.00 +3,000.0%N/A0.4 $2.16 2/28/2020100 shares $165.00 -96.6%N/A0 $1.65 2/14/20202,900 shares $7,540.00 +11.5%N/A0.2 $2.60 1/31/20202,600 shares $9,100.00 -58.1%N/A0.2 $3.50 1/15/20206,200 shares $23,250.00 +158.3%N/A0.4 $3.75 12/31/20192,400 shares $8,304.00 +14.3%N/A0.1 $3.46 IMRN Short Interest - Frequently Asked Questions What is Immuron's current short interest? Short interest is the volume of Immuron shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 14,700 shares of IMRN short. Learn More on Immuron's current short interest. Is Immuron's short interest increasing or decreasing? Immuron saw a decrease in short interest in April. As of April 30th, there was short interest totaling 14,700 shares, a decrease of 39.8% from the previous total of 24,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Immuron's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Immuron: Purple Biotech Ltd (1.18%), Kiora Pharmaceuticals, Inc. (0.56%), RedHill Biopharma Ltd. (2.38%), Eterna Therapeutics Inc. (1.15%), Imunon, Inc. (3.95%), Pieris Pharmaceuticals, Inc. (1.12%), FSD Pharma Inc. (1.00%), Edesa Biotech, Inc. (0.69%), Akari Therapeutics, Plc (0.03%), Monopar Therapeutics Inc. (1.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Immuron stock? Short selling IMRN is an investing strategy that aims to generate trading profit from Immuron as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Immuron? A short squeeze for Immuron occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMRN, which in turn drives the price of the stock up even further. How often is Immuron's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMRN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Purple Biotech Short Interest Data Kiora Pharmaceuticals Short Interest Data RedHill Biopharma Short Interest Data Eterna Therapeutics Short Interest Data Imunon Short Interest Data Pieris Pharmaceuticals Short Interest Data FSD Pharma Short Interest Data Edesa Biotech Short Interest Data Akari Therapeutics Short Interest Data Monopar Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMRN) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account Before It’s Too LateWeiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace